Compile Data Set for Download or QSAR
Found 22 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 9561
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474381(US10858368, Entry 1 | US11319327, Entry 1)copy SMILEScopy InChI
Affinity DataIC50: 18nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474387(US10858368, Entry 7 | US11319327, Entry 7)copy SMILEScopy InChI
Affinity DataIC50: 34nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474388(US10858368, Entry 8 | US11319327, Entry 8)copy SMILES
Affinity DataIC50: 46nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474394(US10858368, Entry 14 | US11319327, Entry 14)copy SMILEScopy InChI
Affinity DataIC50: 47nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474396(US10858368, Entry 16 | US11319327, Entry 16)copy SMILEScopy InChI
Affinity DataIC50: 56nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474390(US10858368, Entry 10 | US11319327, Entry 10)copy SMILEScopy InChI
Affinity DataIC50: 64nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474400(US10858368, Entry 20 | US11319327, Entry 20)copy SMILEScopy InChI
Affinity DataIC50: 67nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474401(US10858368, Entry 21 | US11319327, Entry 21)copy SMILEScopy InChI
Affinity DataIC50: 75nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474391(US10858368, Entry 11 | US11319327, Entry 11)copy SMILEScopy InChI
Affinity DataIC50: 77nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474383(US10858368, Entry 3 | US11319327, Entry 3)copy SMILEScopy InChI
Affinity DataIC50: 81nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474398(US10858368, Entry 18 | US11319327, Entry 18)copy SMILEScopy InChI
Affinity DataIC50: 86nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474386(US10858368, Entry 6 | US11319327, Entry 6)copy SMILEScopy InChI
Affinity DataIC50: 93nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474393(US10858368, Entry 13 | US11319327, Entry 13)copy SMILEScopy InChI
Affinity DataIC50: 96nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474385(US10858368, Entry 5 | US11319327, Entry 5)copy SMILEScopy InChI
Affinity DataIC50: 102nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474392(US10858368, Entry 12 | US11319327, Entry 12)copy SMILEScopy InChI
Affinity DataIC50: 108nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474397(US10858368, Entry 17 | US11319327, Entry 17)copy SMILEScopy InChI
Affinity DataIC50: 116nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474384(US10858368, Entry 4 | US11319327, Entry 4)copy SMILEScopy InChI
Affinity DataIC50: 122nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474395(US10858368, Entry 15 | US11319327, Entry 15)copy SMILEScopy InChI
Affinity DataIC50: 131nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474382(US10858368, Entry 2 | US11319327, Entry 2)copy SMILEScopy InChI
Affinity DataIC50: 149nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474402(US10858368, Entry 22 | US11319327, Entry 22)copy SMILEScopy InChI
Affinity DataIC50: 202nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474389(US10858368, Entry 9 | US11319327, Entry 9)copy SMILEScopy InChI
Affinity DataIC50: 303nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; PRAEVENTIX, LLC

US Patent
LigandPNGBDBM474399(US10858368, Entry 19 | US11319327, Entry 19)copy SMILEScopy InChI
Affinity DataIC50: 461nMAssay Description:A solution of the compound of the disclosure to be tested is prepared as a 1-mg/ml stock in Assay Buffer or DMSO according to its solubility. A simil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FR00QNUS Patent